Cargando…
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Pancreatic cancer (PC) is the third-leading cause of cancer deaths. The overall 5-year survival rate of PC is 9%, and this rate for metastatic PC is below 3%. However, the PC-induced death cases will increase about 2-fold by 2060. Many factors such as genetic and environmental factors and metabolic...
Autores principales: | Zhang, Chun-Ye, Liu, Shuai, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827589/ https://www.ncbi.nlm.nih.gov/pubmed/36632312 http://dx.doi.org/10.3748/wjg.v28.i48.6827 |
Ejemplares similares
-
Molecular markers contribute to the clinical diagnosis for pancreatic cystic neoplasms
por: Liu, Zhen, et al.
Publicado: (2020) -
Molecular Mechanisms and Current Treatment Options for Cancer Cachexia
por: Ahmad, Syed Sayeed, et al.
Publicado: (2022) -
Molecular Markers in the Diagnosis and Treatment of Cancer
por: Gokden, Murat, et al.
Publicado: (2015) -
Pediatric Ureteroceles: Diagnosis, Management and Treatment Options
por: Günşar, Cüneyt, et al.
Publicado: (2010) -
New Treatment Options in Metastatic Pancreatic Cancer
por: Fudalej, Marta, et al.
Publicado: (2023)